SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tutogen Medical, Inc. (OTCBB: TTGN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: leigh aulper who started this subject11/13/2001 7:14:25 AM
From: leigh aulper   of 56
 
Sulzer Spine-Tech Launches Puros(TM) Accugraft(TM) for Lumbar Spinal Fusions


MINNEAPOLIS, Nov. 13 /PRNewswire/ -- Sulzer Spine-Tech, a subsidiary of Sulzer Medica Ltd. based in Minneapolis, Minnesota, has begun marketing the Tutogen Medical ALIF, a biological specialty graft under the trade name Accugraft(TM). This is Spine-Tech's first biological specialty graft, and will compete aggressively in the $169 million allograft market, a market that is growing over 30% annually.

"Accugraft incorporates the Tutoplast(R) process which preserves the biomechanical integrity of the graft, removes antigenicity and inactivates viruses," said Manfred Kruger, President and CEO for Tutogen Medical. Sulzer Spine-Tech is the exclusive distributor of Tutogen's biological tissue for spinal applications. Kruger continued, "the unique cortico-cancellous construction of this graft provides for maximum support and optimal fusion potential."

"Accugraft(TM) gives our surgeon customers another option for their anterior lumbar spinal fusion patients," said Mike McCormick, Vice President of Sales and Marketing for Spine-Tech. "Accugraft(TM) can be used in conjunction with our Silhouette(TM) pedicle screw system to provide maximum support and stabilization," McCormick added.

Lumbar spinal fusion is a common treatment for patients experiencing chronic, disabling low back and leg pain stemming from degenerative disc disease. Accugraft will be used to restore the disc height to normal and thereby relieve the patient's pain.

Sulzer Spine-Tech, headquartered in Minneapolis, Minnesota, develops, manufactures and markets medical devices for the spinal markets worldwide. Since its inception in 1991, Sulzer Spine-Tech has focused on designing and manufacturing comprehensive spine care solutions to improve patients' quality of life. Sulzer Spine-Tech is a subsidiary of Sulzer Medica (NYSE: SM) www.spinetech.com

Tutogen Medical, Inc. (Amex: TTG) utilizes its patented Tutoplast(R) process of tissue preservation and viral inactivation, to manufacture bio-implants for orthopedic, neurosurgical, reconstructive and general surgical indications. The Company's Tutoplast(R) products are sold and distributed worldwide. www.tutogen.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext